Pimobendan: A Treatment for Preclinical Mitral Valve Disease in Dogs | Feature Video
ฝัง
- เผยแพร่เมื่อ 12 มิ.ย. 2023
- Pimobendan has been used to treat symptomatic heart failure in dogs for years, but after a study showed that it delayed the onset of congestive heart failure in dogs with preclinical myxomatous mitral valve disease, it received conditional approval from the U.S. FDA to treat those cases. What does that mean for your patients? Learn more in this video.
Our little dog is on Pimobendan. I was under the impression that it delayed symptoms of CHF by about two years. We have had our dog seen by vet cardiologists in Minnesota.
My dog also sees the cardiology team at the UofM and this drug has been a total game changer. So thankful for it!
Did you get a positive or negative reaction?
@@disembark 100% positive. There is no doubt it is giving my dog a longer life. She acts like her old self again and looks so much better physically. Simply amazing. She also takes benazapril and Spironolactone
Do you have an opinion on the new surgery, TEERS, to repair mitral valves in small dogs? The University of Colorado has been first in doing this ... I believe ... and it is also being done at the University of Minnesota Veterinary Center. It's not experimental ... but they have not been doing it for very long.
My 15 yr old Shi-Poo has been on this when the first onset of symptoms (coughing) happened, this was 2 years ago. However for some reason he's on 2.5mg 2x a day, when labels say 1.25, 2x a day for a 10-11lbs dog. 5mg a day is for a dog double his size.
Ask your cardiologist why they are overdosing your dog. You as the pet owner have the final decision. Give your dog what is best for him/her.
So it only showed survival in dogs with clinical signs (2:45)